Partial adrenalectomy: The National Cancer Institute experience

To report our experience of partial adrenalectomy and demonstrate whether adrenal function can be preserved in patients with hereditary adrenal pheochromocytoma. Total adrenalectomy has largely been used in the treatment of patients with hereditary adrenal pheochromocytomas. Adrenal cortical-sparing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2005-07, Vol.66 (1), p.19-23
Hauptverfasser: Diner, Eric K., Franks, Michael E., Behari, Ashish, Linehan, W. Marston, Walther, McClellan M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23
container_issue 1
container_start_page 19
container_title Urology (Ridgewood, N.J.)
container_volume 66
creator Diner, Eric K.
Franks, Michael E.
Behari, Ashish
Linehan, W. Marston
Walther, McClellan M.
description To report our experience of partial adrenalectomy and demonstrate whether adrenal function can be preserved in patients with hereditary adrenal pheochromocytoma. Total adrenalectomy has largely been used in the treatment of patients with hereditary adrenal pheochromocytomas. Adrenal cortical-sparing surgery is an alternative approach that aims to balance tumor removal with preservation of adrenocortical function. From 1995 to 2004, 33 patients with hereditary pheochromocytoma presented with adrenal masses. Partial adrenalectomy (open or laparoscopic) was performed if normal adrenocortical tissue was evident on preoperative imaging or intraoperative ultrasonography. Various operative parameters, as well as postoperative function of the residual adrenal remnants, were determined. Of the 33 patients, 8 underwent open partial adrenalectomy and 25 laparoscopic partial adrenalectomy during a 10-year period. Ten patients underwent simultaneous, bilateral partial adrenalectomy and 8 underwent surgery on a solitary adrenal gland, 4 of whom received postoperative steroid replacement (stopped in 3 after 1 to 3 months). All other patients had normal catecholamine levels and remained tumor free by imaging at a mean follow-up of 36 months (range 3 to 102). Partial adrenalectomy can preserve adrenal function in patients with adrenal masses. The laparoscopic approach is technically safe and associated with less morbidity without compromising tumor removal. With careful surgical planning, especially in patients with tumors in solitary glands, adrenocortical function may be preserved, thereby avoiding the morbidity associated with medical adrenal replacement.
doi_str_mv 10.1016/j.urology.2005.01.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68031811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429505000816</els_id><sourcerecordid>68031811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-bb1bfd06b11f2ce4a3e600e624ac13100111c26573073ee4ecdd6dbcc206e0cf3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbK3-BCUXvSXOJNlN46VI8aNQ1EM9L5vNRLekTd1NxP57tzbQo6eBl-edGR7GLhEiBBS3y6izTd18bKMYgEeAEUB-xIbI4yzM85wfs6FPIEzjnA_YmXNLABBCZKdsgDwXiGk6ZJM3ZVuj6kCVltaqJt02q-1dsPik4EW1pvFZMFVrTTaYrV1r2q6lgH42ZA359JydVKp2dNHPEXt_fFhMn8P569Nsej8PdcrzNiwKLKoSRIFYxZpSlZAAIBGnSmOCAIioY8GzBLKEKCVdlqIstI5BEOgqGbGb_d6Nbb46cq1cGaeprtWams5JMYYEx4ge5HtQ28Y5S5XcWLNSdisR5M6cXMrenNyZk4DSe_K9q_5AV6yoPLR6VR647gHltKor66UYd-AyEAnnO26y58jr-DZkpdN_qkpjvV1ZNuafV34BGfuPdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68031811</pqid></control><display><type>article</type><title>Partial adrenalectomy: The National Cancer Institute experience</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Diner, Eric K. ; Franks, Michael E. ; Behari, Ashish ; Linehan, W. Marston ; Walther, McClellan M.</creator><creatorcontrib>Diner, Eric K. ; Franks, Michael E. ; Behari, Ashish ; Linehan, W. Marston ; Walther, McClellan M.</creatorcontrib><description>To report our experience of partial adrenalectomy and demonstrate whether adrenal function can be preserved in patients with hereditary adrenal pheochromocytoma. Total adrenalectomy has largely been used in the treatment of patients with hereditary adrenal pheochromocytomas. Adrenal cortical-sparing surgery is an alternative approach that aims to balance tumor removal with preservation of adrenocortical function. From 1995 to 2004, 33 patients with hereditary pheochromocytoma presented with adrenal masses. Partial adrenalectomy (open or laparoscopic) was performed if normal adrenocortical tissue was evident on preoperative imaging or intraoperative ultrasonography. Various operative parameters, as well as postoperative function of the residual adrenal remnants, were determined. Of the 33 patients, 8 underwent open partial adrenalectomy and 25 laparoscopic partial adrenalectomy during a 10-year period. Ten patients underwent simultaneous, bilateral partial adrenalectomy and 8 underwent surgery on a solitary adrenal gland, 4 of whom received postoperative steroid replacement (stopped in 3 after 1 to 3 months). All other patients had normal catecholamine levels and remained tumor free by imaging at a mean follow-up of 36 months (range 3 to 102). Partial adrenalectomy can preserve adrenal function in patients with adrenal masses. The laparoscopic approach is technically safe and associated with less morbidity without compromising tumor removal. With careful surgical planning, especially in patients with tumors in solitary glands, adrenocortical function may be preserved, thereby avoiding the morbidity associated with medical adrenal replacement.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2005.01.009</identifier><identifier>PMID: 15961144</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adrenal Gland Neoplasms - surgery ; Adrenalectomy - methods ; Adult ; Aged ; Biological and medical sciences ; Child ; Humans ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Pheochromocytoma - surgery</subject><ispartof>Urology (Ridgewood, N.J.), 2005-07, Vol.66 (1), p.19-23</ispartof><rights>2005 Elsevier Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-bb1bfd06b11f2ce4a3e600e624ac13100111c26573073ee4ecdd6dbcc206e0cf3</citedby><cites>FETCH-LOGICAL-c459t-bb1bfd06b11f2ce4a3e600e624ac13100111c26573073ee4ecdd6dbcc206e0cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2005.01.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17063554$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15961144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diner, Eric K.</creatorcontrib><creatorcontrib>Franks, Michael E.</creatorcontrib><creatorcontrib>Behari, Ashish</creatorcontrib><creatorcontrib>Linehan, W. Marston</creatorcontrib><creatorcontrib>Walther, McClellan M.</creatorcontrib><title>Partial adrenalectomy: The National Cancer Institute experience</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To report our experience of partial adrenalectomy and demonstrate whether adrenal function can be preserved in patients with hereditary adrenal pheochromocytoma. Total adrenalectomy has largely been used in the treatment of patients with hereditary adrenal pheochromocytomas. Adrenal cortical-sparing surgery is an alternative approach that aims to balance tumor removal with preservation of adrenocortical function. From 1995 to 2004, 33 patients with hereditary pheochromocytoma presented with adrenal masses. Partial adrenalectomy (open or laparoscopic) was performed if normal adrenocortical tissue was evident on preoperative imaging or intraoperative ultrasonography. Various operative parameters, as well as postoperative function of the residual adrenal remnants, were determined. Of the 33 patients, 8 underwent open partial adrenalectomy and 25 laparoscopic partial adrenalectomy during a 10-year period. Ten patients underwent simultaneous, bilateral partial adrenalectomy and 8 underwent surgery on a solitary adrenal gland, 4 of whom received postoperative steroid replacement (stopped in 3 after 1 to 3 months). All other patients had normal catecholamine levels and remained tumor free by imaging at a mean follow-up of 36 months (range 3 to 102). Partial adrenalectomy can preserve adrenal function in patients with adrenal masses. The laparoscopic approach is technically safe and associated with less morbidity without compromising tumor removal. With careful surgical planning, especially in patients with tumors in solitary glands, adrenocortical function may be preserved, thereby avoiding the morbidity associated with medical adrenal replacement.</description><subject>Adolescent</subject><subject>Adrenal Gland Neoplasms - surgery</subject><subject>Adrenalectomy - methods</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pheochromocytoma - surgery</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1Lw0AQhhdRbK3-BCUXvSXOJNlN46VI8aNQ1EM9L5vNRLekTd1NxP57tzbQo6eBl-edGR7GLhEiBBS3y6izTd18bKMYgEeAEUB-xIbI4yzM85wfs6FPIEzjnA_YmXNLABBCZKdsgDwXiGk6ZJM3ZVuj6kCVltaqJt02q-1dsPik4EW1pvFZMFVrTTaYrV1r2q6lgH42ZA359JydVKp2dNHPEXt_fFhMn8P569Nsej8PdcrzNiwKLKoSRIFYxZpSlZAAIBGnSmOCAIioY8GzBLKEKCVdlqIstI5BEOgqGbGb_d6Nbb46cq1cGaeprtWams5JMYYEx4ge5HtQ28Y5S5XcWLNSdisR5M6cXMrenNyZk4DSe_K9q_5AV6yoPLR6VR647gHltKor66UYd-AyEAnnO26y58jr-DZkpdN_qkpjvV1ZNuafV34BGfuPdA</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>Diner, Eric K.</creator><creator>Franks, Michael E.</creator><creator>Behari, Ashish</creator><creator>Linehan, W. Marston</creator><creator>Walther, McClellan M.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050701</creationdate><title>Partial adrenalectomy: The National Cancer Institute experience</title><author>Diner, Eric K. ; Franks, Michael E. ; Behari, Ashish ; Linehan, W. Marston ; Walther, McClellan M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-bb1bfd06b11f2ce4a3e600e624ac13100111c26573073ee4ecdd6dbcc206e0cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adrenal Gland Neoplasms - surgery</topic><topic>Adrenalectomy - methods</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pheochromocytoma - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diner, Eric K.</creatorcontrib><creatorcontrib>Franks, Michael E.</creatorcontrib><creatorcontrib>Behari, Ashish</creatorcontrib><creatorcontrib>Linehan, W. Marston</creatorcontrib><creatorcontrib>Walther, McClellan M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diner, Eric K.</au><au>Franks, Michael E.</au><au>Behari, Ashish</au><au>Linehan, W. Marston</au><au>Walther, McClellan M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial adrenalectomy: The National Cancer Institute experience</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>66</volume><issue>1</issue><spage>19</spage><epage>23</epage><pages>19-23</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>To report our experience of partial adrenalectomy and demonstrate whether adrenal function can be preserved in patients with hereditary adrenal pheochromocytoma. Total adrenalectomy has largely been used in the treatment of patients with hereditary adrenal pheochromocytomas. Adrenal cortical-sparing surgery is an alternative approach that aims to balance tumor removal with preservation of adrenocortical function. From 1995 to 2004, 33 patients with hereditary pheochromocytoma presented with adrenal masses. Partial adrenalectomy (open or laparoscopic) was performed if normal adrenocortical tissue was evident on preoperative imaging or intraoperative ultrasonography. Various operative parameters, as well as postoperative function of the residual adrenal remnants, were determined. Of the 33 patients, 8 underwent open partial adrenalectomy and 25 laparoscopic partial adrenalectomy during a 10-year period. Ten patients underwent simultaneous, bilateral partial adrenalectomy and 8 underwent surgery on a solitary adrenal gland, 4 of whom received postoperative steroid replacement (stopped in 3 after 1 to 3 months). All other patients had normal catecholamine levels and remained tumor free by imaging at a mean follow-up of 36 months (range 3 to 102). Partial adrenalectomy can preserve adrenal function in patients with adrenal masses. The laparoscopic approach is technically safe and associated with less morbidity without compromising tumor removal. With careful surgical planning, especially in patients with tumors in solitary glands, adrenocortical function may be preserved, thereby avoiding the morbidity associated with medical adrenal replacement.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15961144</pmid><doi>10.1016/j.urology.2005.01.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2005-07, Vol.66 (1), p.19-23
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_68031811
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Adolescent
Adrenal Gland Neoplasms - surgery
Adrenalectomy - methods
Adult
Aged
Biological and medical sciences
Child
Humans
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Pheochromocytoma - surgery
title Partial adrenalectomy: The National Cancer Institute experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A45%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20adrenalectomy:%20The%20National%20Cancer%20Institute%20experience&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Diner,%20Eric%20K.&rft.date=2005-07-01&rft.volume=66&rft.issue=1&rft.spage=19&rft.epage=23&rft.pages=19-23&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/j.urology.2005.01.009&rft_dat=%3Cproquest_cross%3E68031811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68031811&rft_id=info:pmid/15961144&rft_els_id=S0090429505000816&rfr_iscdi=true